On 31 January 2022, the ENDFLU Consortium has provided the Periodic Communication Report to the European Union.
The Consortium is proud to present the presentations related to ENDFLU from the start of the project to this date.
# | Title | Authors | Journal | DOI and URL |
---|---|---|---|---|
1 | In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression | Silvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, Lei Deng, Emma R. Job, Kenny Roose, Bert Schepens, Lien Van Hoecke, Philippe Lemey, Xavier Saelens | mBio | 10.1128/mBio.00745-21 View here |
2 | Influenza vaccines: successes and continuing challenges | Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan, Albert D M E Osterhaus | The Journal of Infectious Diseases | 10.1093/infdis/jiab269 View here |
3 | Protective efficacy of recombinant influenza hemagglutinin ectodomain fusions | Mittal, N.; Sengupta, N.; Malladi, S.K.; Reddy, P.; Bhat, M.; Rajmani, R.S.; Sedeyn, K.; Saelens, X.; Dutta, S.; Varadarajan, R. | Viruses | 10.3390/v13091710 View here |
4 | The identification of novel promoters and terminators for protein expression and metabolic engineering applications in Kluyveromyces marxianus | Pradeep Kumar, Debendra Kumar Sahoo, Deepak Sharma | Metab. Eng. Commun. | 10.1016/j.mec.2020.e00160 View here |
5 | Influenza Neuraminidase Characteristics and Potential as a Vaccine Target | Creytens Sarah, Pascha Mirte N., Ballegeer Marlies, Saelens Xavier, de Haan Cornelis A. M. | Front. Immunol. | 10.3389/fimmu.2021.786617 View here |
6 | Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem Immunogens | Kar U, Khaleeq S, Garg P, Bhat M, Reddy P, Vignesh VS, Upadhyaya A, Das M, Chakshusmathi G, Pandey S, Dutta S, Varadarajan R | Front. Immunol. | 10.3389/fimmu.2022.890622 View here |